Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Technical Analysis
$16.94
Insights
- Amneal Pharmaceuticals Inc. Class A is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Amneal Pharmaceuticals Inc. Class A stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Amneal Pharmaceuticals Inc. Class A stock is Range bound.
- Based on analysis of the Pivot Points, the current market trend for Amneal Pharmaceuticals Inc. Class A stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 43.68 | Neutral |
Stochastic | 20.15, 13.75 | Neutral |
Ultimate Oscillator | 41.68 | Neutral |
Stochastic Relative Strength Index | 7.9, 21.58 | Neutral |
Moving Average Convergence Divergence | -0.09, 0.01 | Sell |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 17.64 | Sell |
20 | 17.78 | Buy |
50 | 17.76 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 17.57 | Sell |
20 | 17.7 | Buy |
50 | 17.34 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 17.67 | Neutral |
20 | 17.75 | Neutral |
50 | 17.76 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 17.36 | Sell |
20 | 17.61 | Sell |
50 | 18.38 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 17.26 | Sell |
20 | 17.32 | Sell |
50 | 18.13 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 17.72 |
Resistance L2 | 17.56 |
Resistance L1 | 17.3 |
Pivot Point | 17.14 |
Support L1 | 16.89 |
Support L2 | 16.73 |
Support L3 | 16.47 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.